4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

The online-only Data Supplement is available with this article at http://circ. ahajournals.
org/lookup/suppl/doi: 10.1161/CIR. 0b013e318276ce9b/-/DC1. The online-only …

It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

This revision of the “ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers
and Antiarrhythmia Devices” updates the previous versions published in 1984, 1991, 1998 …

Heart failure (HF) is a major and growing public health problem in the United States.
Approximately 5 million patients in this country have HF, and over 550 000 patients are …

Late-breaking clinical trials presented at the 2005, 2006, and 2007 annual scientific
meetings of the ACCF, AHA, and European Society of Cardiology, as well as selected other …

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and
the Prevention of Sudden Cardiac Death: A Report of the American College of …

The members of the Task Force on Sudden Death dedicate this paper to the memory of our
former friend and colleague, Professor Ronald WF Campbell. Ronnie spent his life working …

The American College of Cardiology (ACC)/American Heart Association (AHA) Task Force
on Practice Guidelines regularly reviews existing guidelines to determine when an update or …